The radiosensitizing effect of fluorocyclopentenyl-cytosine (RX-3117) in ovarian and lung cancer cell lines.

about

The radiosensitizing effect of fluorocyclopentenyl-cytosine (RX-3117) in ovarian and lung cancer cell lines.

Item

http://www.wikidata.org/entity/Q38728091

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The radiosensitizing effect of ...... an and lung cancer cell lines.

@en

type

Item

label

The radiosensitizing effect of ...... an and lung cancer cell lines.

@en

prefLabel

The radiosensitizing effect of ...... an and lung cancer cell lines.

@en

P1476

The radiosensitizing effect of ...... an and lung cancer cell lines.

@en

P2093

Deog J Kim

http://www.w3.org/2001/XMLSchema#string

Dzjemma Sarkisjan

http://www.w3.org/2001/XMLSchema#string

Evelyn Smit

http://www.w3.org/2001/XMLSchema#string

Godefridus J Peters

http://www.w3.org/2001/XMLSchema#string

Jaap van den Berg

http://www.w3.org/2001/XMLSchema#string

Young B Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes.

The mechanism of action of radiosensitization of conventional chemotherapeutic agents.

Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer.

Antimetabolite radiosensitizers.

Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a review

Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation.

Effects of 5-azacytidine and its 2'-deoxyderivative on cell differentiation and DNA methylation.

Mode of action and effects of 5-azacytidine and of its derivatives in eukaryotic cells.

Novel developments in the use of antimetabolites.

Radiosensitization by thymidine phosphorylase inhibitor in thymidine phosphorylase negative and overexpressing bladder cancer cell lines.

P304

619-630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15257770.2016.1216565

http://www.w3.org/2001/XMLSchema#string

P433

10-12

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27906620

http://www.w3.org/2001/XMLSchema#string